R
Robert Prosecky
Researcher at Masaryk University
Publications - 19
Citations - 204
Robert Prosecky is an academic researcher from Masaryk University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 11 publications receiving 87 citations. Previous affiliations of Robert Prosecky include Mercy Medical Center (Baltimore, Maryland).
Papers
More filters
Journal ArticleDOI
Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Alena Liskova,Marek Samec,Lenka Koklesova,Samson Mathews Samuel,Kevin Zhai,Raghad Khalid Al-Ishaq,Mariam Abotaleb,Vladimir Nosal,Karol Kajo,Milad Ashrafizadeh,Ali Zarrabi,Aranka Brockmueller,Mehdi Shakibaei,Peter Sabaka,Ioana Mozos,David Ullrich,Robert Prosecky,Giampiero La Rocca,Martin Caprnda,Dietrich Büsselberg,Luis Rodrigo,Peter Kruzliak,Peter Kubatka +22 more
TL;DR: The potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity, was discussed in this paper.
Journal ArticleDOI
Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women : A 10-year follow-up.
Matej Bendzala,Peter Sabaka,Martin Caprnda,Andrea Komornikova,Maria Bisahova,Ruth Baneszova,Daniel Petrovič,Daniel Petrovič,Robert Prosecky,Luis Rodrigo,Peter Kruzliak,Andrej Dukát +11 more
TL;DR: The AIP is positively associated with the risk of all-cause death in elderly women with arterial hypertension independent of age, smoking habits, statin therapy and comorbidities.
Journal ArticleDOI
Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
Martin Caprnda,Peter Kubatka,Katarina Gazdikova,Iveta Gasparova,Vanda Valentova,Nadezda Stollárová,Giampiero La Rocca,Nazarii Kobyliak,Jozef Dragasek,Ioana Mozos,Robert Prosecky,Dario Siniscalco,Dietrich Büsselberg,Luis Rodrigo,Peter Kruzliak +14 more
TL;DR: An overview of recent studies on the potential therapeutic use of mesenchymal stem cells, neural stem cells (NSCs), embryonic stem cells(ESCs), induced pluripotent stem cell (iPSCs), and perinatal stem cells to neurodegenerative disorders are given and their immunomodulatory mechanisms of action in specific therapeutic modalities are described.
Journal ArticleDOI
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis
Marek Samec,Alena Liskova,Lenka Koklesova,Samson Mathews Samuel,Radovan Murín,Pavol Zubor,Jan Bujnak,Taeg Kyu Kwon,Dietrich Büsselberg,Robert Prosecky,Martin Caprnda,Luis Rodrigo,Rachele Ciccocioppo,Peter Kruzliak,Peter Kubatka +14 more
TL;DR: This comprehensive study focuses on immunomodulating potential of phytochemicals and their impact on regulation of immune response during cancer development, immune tolerance, and immune escape and clinical application of phydochemical as modulators of host immunity against cancer may represent perspective approach in anticancer therapy.
Journal ArticleDOI
MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma
Yulian Mytsyk,Yuriy Borys,Lesia Tumanovska,D. O. Stroy,Askold Kucher,Katarina Gazdikova,Luis Rodrigo,Peter Kruzliak,Peter Kruzliak,Robert Prosecky,Peter Urdzík,Victor E. Dosenko +11 more
TL;DR: The tissue expression of miR-15a could be used as a potential prognostic molecular biomarker for conventional RCC and was strongly associated with poor histologic prognostic features of ccRCC.